Rapid Testing reinvented
Rapid Testing reinvented
MedMira Rapid Vertical Flow Technology™
Our technology platform is a scalable innovation with the potential to transform early diagnosis and improve health outcomes globally. RVF Technology™ is the core engine behind our rapid testing solutions for infectious, sexually transmitted, tropical diseases and other chronic healthcare conditions. Speed, accuracy and multiplexing are the hallmarks of our technology which has passed rigorous medical device approval processes worldwide and is trusted by healthcare providers, governments, and aid organizations. We share our technology with fellow innovators through collaborations, partnerships, and licensing.
OUR CORE ENGINE
The technology facilitates the formation of highly specific antigen-antibody reactions allowing specific biomarkers in many sample types, including human whole blood, serum or plasma, to be captured and visualized on a unique membrane. The simple 3-step test procedure involves adding the specimen to the device and allowing it to flow through the membrane. If the specimen contains the target antibodies or antigens, they are captured on the test membrane and can be visually interpreted immediately after the addition of a detection reagent. Our technology platform is unique in its ability to detect multiple biomarkers specific to several diseases using a single cartridge.
Learn more about MedMira RVF Technology™ vs. Lateral Flow
Learn more about MedMira RVF Technology™ vs. Traditional Flow Through
-
Rapid
RVF Technology™ delivers instant results, enabling timely clinical decisions and improving workflow efficiency.
-
Accurate
Delivers high sensitivity and specificity, reliably detecting even low concentrations of target biomarkers.
-
Reliable
Provides consistent, reproducible performance with minimal user error. Precision pipetting, sample manipulation, specialized equipment and training are not required to perform any of MedMira’s rapid tests.
-
Scalable
Our platform uniquely detects multiple biomarkers simultaneously - like our Multiplo tests delivering up to four results from one cartridge and one drop of specimen.
Learn more about our technology in the video.
I required an all-in-one solution for research use with technical support to overcome development roadblocks. I also sought follow-on support to assist with future commercialization. MedMira’s Miriad® Rapid Vertical Flow Assay Toolkit provided the answer.
Dr. Joaquin Patarroyo
Professor & Intellectual Property Advisor for Patsos Biotecnologia, Universisdade Federal de Vicosa, Brazil
From Lab to Field
RVF Technology™ delivers reliable rapid testing, from mobile clinics and military operations to disaster zones, blood banks, and remote field sites. It adapts wherever fast, dependable results matter.
Building Credibility
Key Metrics and Regulatory Approvals You Can Trust
- Key Metrics
Proven performance is at the core of everything we do. Comprehensive clinical data and product-specific performance results are available on each product page.
- Regulatory Approvals
Each test is validated in compliance with regulatory standards. Specific approvals, including FDA, Health Canada, and others, are listed per product.
Driving Innovation Through Collaborations
Our partnerships with industry leaders and research institutions strengthen our mission to shape the future of rapid diagnostic testing.
MedMira’s intellectual property portfolio protects our innovative rapid testing solutions, with patents granted across key markets:
Our Rapid Vertical Flow Technology™ holds a myriad of possibilities for researchers and developers of rapid testing solutions.
We offer researchers access to it, and the twenty years of research it took to get to this point, through licensing agreements, consulting, TAG conjugation service, and a gateway product called the Miriad® RVF Toolkit. Through these programs we are helping to lower the barriers to new product market entry in to the global diagnostics marketplace, which traditionally has been complicated by the numerous patents that govern competitive technology platforms.
Find out more about our Miriad® RVF Toolkit, and accelerate your test development.
The swiftest route to the global market is to engage our experts to convert your concept or existing test platforms to our Rapid Vertical Flow Technology™. Platform conversions, including proof-of-concept and prototype device can typically be made, using existing reagents, within three to six months. Under the principles of Design Control, our development team can convert your concept or test to the rapid vertical flow technology platform and perform initial analyses of the prototypes.
Transform your test in months, not years.
Our facility is fully compliant with cGMP and ISO 13485:2003 standards. The entire facility is routinely inspected by numerous regulators to maintain those certifications. We can manufacture your product in whole or in part under our proven quality system, and customize your product’s design and packaging to meet your sales and marketing requirements.
Your product. Our expertise and facilities.
